312946-35-3

Basic information

• Product Name: Acetic acid, [(3,4-dihydro-4-oxo-3,5-diphenylthieno[2,3-d]pyrimidin-2-yl)thio]-, ethyl ester
• CAS NO: 312946-35-3
• Molecular Formula: C22H18N2O3S2
• Molecular Weight: 422.529
• Mol File: 312946-35-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Acetic acid, [(3,4-dihydro-4-oxo-3,5-diphenylthieno[2,3-d]pyrimidin-2-yl)thio]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, [(3,4-dihydro-4-oxo-3,5-diphenylthieno[2,3-d]pyrimidin-2-yl)thio]-, ethyl ester(312946-35-3)
• EPA Substance Registry System: Acetic acid, [(3,4-dihydro-4-oxo-3,5-diphenylthieno[2,3-d]pyrimidin-2-yl)thio]-, ethyl ester(312946-35-3)

Safety Data

• Hazardous Substances Data: 312946-35-3(Hazardous Substances Data)

Upstream product

• 98-86-2 acetophenone 
• 103-72-0 phenyl isothiocyanate 
• 132605-18-6 4-Phenyl-2-(3-phenyl-thioureido)-thiophene-3-carboxylic acid ethyl ester 
• 4815-36-5 ethyl 2-amino-4-phenyl-thiophene-3-carboxylate 
• 105-36-2 ethyl bromoacetate 
• 142465-09-6 2-mercapto-3,5-diphenyl-3H-thieno[2,3-d]pyrimidin-4-one 

Downstream Products

• 312946-37-5 LDN-27219 

Relevant articles and documents

SUBSTITUED 3,4-DIHYDROTHIENO [2,3-D] PYRMIDINES AS TISSUE TRANSGLUTAMINASE INHIBITORS

The present invention provides novel compounds and methods useful for treating transglutaminase associated disorders such as celiac spru, Alzheimer's disease and Huntington's disease. Certain compounds of the invention are tissue transglutaminase inhibito